Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
Li Chen(Shanghai Medical College of Fudan University), Zhi‐Ming Shao(Fudan University)
Cited by 183
Related Papers
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2021|55
TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis
|Cell Death and Disease|2024|34
Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
|International Journal of Nanomedicine|2015|21